Back to Agenda
Session 0101: HOW TO BUILD A HIGH QUALITY CLINICAL RESEARCH CENTER
Session Chair(s)
Haiyan LI, MD
Professor of Cardiology, Director of Clinical Trial Center
Peking University Third Hospital, China
Successful drug development is highly dependent on the conduct of high-quality clinical trials. Since the initiation of National Major Scientific and Technological Special Project for “Key New Drug Innovation Plan”, more than 60 hospitals nationwide have been funded to set up the high-quality GCP center, designed to provide facility support for innovative drugs clinical research in the "Eleventh Five-Year" and "Twelfth Five-Year" period of time. This session will cover the establishment of the collaborative innovation mechanism, training of professionals, technology platform support, and clinical studies capability enhancement.
Speaker(s)
The Role of Phase I Unit for Drug Development in China
Pei HU
Peking Union Medical College, China
Director, Phase I Unit, Clinical Pharmacological Research Center
Yongjun Wang
Beijing Tiantan Hospital, Capital Medical University, China
Lixin Jiang
National Centre for Cardiovascular Diseases (NCCD), China
Have an account?